Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Cone

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Biology of Reproduction|January 1, 1996
Residence half-life of IgG administered topically to the mouse vaginaJ K Sherwood, L Zeitlin, X Chen, et al.
Biophysical Journal|September 22, 2001
Diffusion of macromolecules and virus-like particles in human cervical mucusS S Olmsted, J L Padgett, A I Yudin, et al.
AIDS (London, England)|June 1, 1993
The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculumT R Moench, K J Whaley, T D Mandrell, et al.
Virology|November 1, 1996
Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2L Zeitlin, K J Whaley, P P Sanna, et al.
Mucosal Immunology|April 13, 2017
Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisitionA C Hearps, D Tyssen, D Srbinovski, et al.
Nature Biotechnology|December 16, 1998
A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpesL Zeitlin, S S Olmsted, T R Moench, et al.
Sexually Transmitted Diseases|July 19, 2001
Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal modelsL Zeitlin, T E Hoen, S L Achilles, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Biology of Reproduction|January 1, 1996
Residence half-life of IgG administered topically to the mouse vaginaJ K Sherwood, L Zeitlin, X Chen, et al.
Biophysical Journal|September 22, 2001
Diffusion of macromolecules and virus-like particles in human cervical mucusS S Olmsted, J L Padgett, A I Yudin, et al.
AIDS (London, England)|June 1, 1993
The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculumT R Moench, K J Whaley, T D Mandrell, et al.
Virology|November 1, 1996
Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2L Zeitlin, K J Whaley, P P Sanna, et al.
Mucosal Immunology|April 13, 2017
Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisitionA C Hearps, D Tyssen, D Srbinovski, et al.
Nature Biotechnology|December 16, 1998
A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpesL Zeitlin, S S Olmsted, T R Moench, et al.
Sexually Transmitted Diseases|July 19, 2001
Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal modelsL Zeitlin, T E Hoen, S L Achilles, et al.
Pageof 5